50 U.S. lawmakers have disclosed 146 CVS Health Corporation trades under the STOCK Act — 69 buys and 76 sells between 2013 and 2026. Congress has been net sellers of CVS, and their disclosed buys are up 31.6% versus the latest close.
*Notional-weighted price return on lawmakers' disclosed buys of CVS, marked to the latest close — per-share (share counts aren't disclosed).
Lawmakers ranked by notional-weighted return on their disclosed CVS buys (last ~3y), marked to the latest close.
| Date | Member | Type | Amount | Est. price | Latest close | Return |
|---|---|---|---|---|---|---|
| 2019-08-27 | Sheldon Whitehouse | BUY | $1K–$15K | $59.19 | $94.99 2026-08-13 | +60.5% |
| 2019-08-12 | Brian Mast | SELL | $50K–$100K | $58.75 | $94.99 2026-08-13 | +11.5% rt |
| 2019-07-23 | John Hoeven | SELL | $50K–$100K | $56.27 | $94.99 2026-08-13 | -13.5% rt |
| 2019-06-24 | David P. Roe | BUY | $1K–$15K | $53.14 | $94.99 2026-08-13 | +78.8% |
| 2019-06-20 | Dean Phillips | SELL | $1K–$15K | $53.87 | $94.99 2026-08-13 | -76.3% exit |
| 2019-06-14 | Bill Flores | SELL | $15K–$50K | $54.17 | $94.99 2026-08-13 | -2.8% rt |
| 2019-05-16 | Sheldon Whitehouse | BUY | $1K–$15K | $52.30 | $94.99 2026-08-13 | +81.6% |
| 2019-05-08 | Bill Flores | BUY | $1K–$15K | $55.74 | $94.99 2026-08-13 | +70.4% |
| 2019-04-11 | Carol Devine Miller | BUY | $15K–$50K | $52.69 | $94.99 2026-08-13 | +80.3% |
| 2019-04-11 | Brian Mast | BUY | $50K–$100K | $52.69 | $94.99 2026-08-13 | +80.3% |
| 2019-02-28 | John F Reed | SELL | $1K–$15K | $57.83 | $94.99 2026-08-13 | -64.3% exit |
| 2019-02-04 | Dean Phillips | SELL | $1K–$15K | $65.91 | $94.99 2026-08-13 | -44.1% exit |
| 2019-02-04 | John F Reed | SELL | $1K–$15K | $65.91 | $94.99 2026-08-13 | -44.1% exit |
| 2019-01-25 | William Cassidy | BUY | $1K–$15K | $65.45 | $94.99 2026-08-13 | +45.1% |
| 2019-01-22 | Robert J. Wittman | BUY | $1K–$15K | $64.92 | $94.99 2026-08-13 | +46.3% |
| 2018-12-27 | Steve Cohen | SELL | $15K–$50K | $65.24 | $94.99 2026-08-13 | -45.6% exit |
| 2018-12-20 | Thomas R Tillis | SELL | $1K–$15K | $66.48 | $94.99 2026-08-13 | -42.9% exit |
| 2018-12-20 | Thomas R Tillis | SELL | $1K–$15K | $66.48 | $94.99 2026-08-13 | -42.9% exit |
| 2018-12-20 | Thomas R Tillis | SELL | $1K–$15K | $66.48 | $94.99 2026-08-13 | -42.9% exit |
| 2018-12-19 | Jerry Moran, | BUY | $1K–$15K | $68.59 | $94.99 2026-08-13 | +38.5% |
| 2018-12-19 | Robert J. Wittman | SELL | $1K–$15K | $68.59 | $94.99 2026-08-13 | -38.5% exit |
| 2018-12-07 | William Cassidy | SELL | $1K–$15K | $74.09 | $94.99 2026-08-13 | -11.9% rt |
| 2018-11-29 | Robert J. Wittman | exchange | $1K–$15K | $80.00 | $94.99 2026-08-13 | +18.7% |
| 2018-11-26 | John A. Yarmuth | SELL | $1K–$15K | $77.84 | $94.99 2026-08-13 | -22.0% exit |
| 2018-06-07 | John Hoeven | BUY | $50K–$100K | $65.02 | $94.99 2026-08-13 | +46.1% |
| 2018-05-14 | JOHN BOOZMAN | BUY | $1K–$15K | $66.82 | $94.99 2026-08-13 | +42.2% |
| 2018-05-04 | James B. Renacci | BUY | $15K–$50K | $63.10 | $94.99 2026-08-13 | +50.5% |
| 2018-04-26 | Gary C Peters | BUY | $1K–$15K | $68.69 | $94.99 2026-08-13 | +38.3% |
| 2018-04-23 | William Cassidy | BUY | $1K–$15K | $65.68 | $94.99 2026-08-13 | +44.6% |
| 2018-04-03 | Sheldon Whitehouse | SELL | $1K–$15K | $62.58 | $94.99 2026-08-13 | -51.8% exit |
| 2018-04-03 | Pete Sessions | SELL | $1K–$15K | $62.58 | $94.99 2026-08-13 | -51.8% exit |
| 2018-03-09 | John F Reed | SELL | $1K–$15K | $69.27 | $94.99 2026-08-13 | -37.1% exit |
| 2017-12-13 | Lois Frankel | SELL | $1K–$15K | $71.62 | $94.99 2026-08-13 | -32.6% exit |
| 2017-11-15 | Lois Frankel | SELL | $1K–$15K | $69.80 | $94.99 2026-08-13 | -36.1% exit |
| 2017-11-15 | Lois Frankel | SELL | $1K–$15K | $69.80 | $94.99 2026-08-13 | -36.1% exit |
| 2017-11-01 | Lois Frankel | SELL | $1K–$15K | $69.00 | $94.99 2026-08-13 | -7.5% rt |
| 2017-10-25 | William Cassidy | BUY | $1K–$15K | $75.53 | $94.99 2026-08-13 | +25.8% |
| 2017-10-25 | William Cassidy | BUY | $1K–$15K | $75.53 | $94.99 2026-08-13 | +25.8% |
| 2017-10-11 | James M Inhofe | SELL | $50K–$100K | $73.90 | $94.99 2026-08-13 | -11.2% rt |
| 2017-10-10 | Carlos Curbelo | SELL | $1K–$15K | $74.71 | $94.99 2026-08-13 | -27.1% exit |
| 2017-09-15 | James M Inhofe | BUY | $50K–$100K | $83.17 | $94.99 2026-08-13 | +14.2% |
| 2017-09-11 | John A. Yarmuth | SELL | $1K–$15K | $79.72 | $94.99 2026-08-13 | -18.1% rt |
| 2017-08-25 | K. Michael Conaway | SELL | $1K–$15K | $75.35 | $94.99 2026-08-13 | -26.1% exit |
| 2017-08-24 | K. Michael Conaway | SELL | $1K–$15K | $75.39 | $94.99 2026-08-13 | -26.0% exit |
| 2017-06-15 | Patty Murray | SELL | $1K–$15K | $80.09 | $94.99 2026-08-13 | +0.7% rt |
| 2017-05-30 | Sheldon Whitehouse | SELL | $15K–$50K | $76.77 | $94.99 2026-08-13 | -5.4% rt |
| 2017-05-24 | Susan M Collins | SELL | $15K–$50K | $76.42 | $94.99 2026-08-13 | +13.0% rt |
| 2017-05-16 | James B. Renacci | BUY | $1K–$15K | $79.12 | $94.99 2026-08-13 | +20.1% |
| 2017-04-28 | James B. Renacci | SELL | $1K–$15K | $82.44 | $94.99 2026-08-13 | -19.5% rt |
| 2017-04-28 | James B. Renacci | BUY | $1K–$15K | $82.44 | $94.99 2026-08-13 | +15.2% |
Return: buys marked to the latest close (open); sells tagged rt are realized round-trips vs a prior disclosed buy; exit = timing (stock move after the sale, seller's perspective).
50 members of the U.S. House and Senate have disclosed CVS Health Corporation transactions under the STOCK Act — 69 purchases and 76 sales. The full member-by-member breakdown, with dates and dollar ranges, is in the table above.
No member of Congress has disclosed a CVS purchase in the last 90 days. STOCK Act filings lag the trade by up to 45 days, so newer buys may still be pending disclosure.
Notional-weighted, lawmakers' disclosed CVS buys are up 31.6% versus the latest close of $94.99. Each trade's own return — and realized round-trips on matched sells — is in the Return column.
Yes. Under the 2012 STOCK Act, members of Congress may buy and sell individual stocks but must publicly disclose each transaction within 45 days. Bargo surfaces those filings so you can see who traded CVS and how it performed.